PFIZER, INC. |
Market Closed -
Other stock markets
|
Pre-market 07:13:59 am | |||
| 28.92 USD | +0.35% |
|
29.02 | +0.36% |
| 10:04am | GSK sells remaining Haleon stake for GBP1.25 billion | AN |
| 08:13am | GSK raises $1.5 bln from sale of remaining Haleon stake | RE |
ETFs positioned on Pfizer, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 14.74% | 254 M€ | +10.74% | - | |
| 9.37% | 17 M€ | +7.73% | - | |
| 3.49% | 9 M€ | -.--% | - | |
| 2.99% | 23 M€ | +13.87% | - | |
| 2.80% | 2 M€ | -.--% | - | |
| 2.70% | 5 M€ | -72.95% | - | |
| 2.45% | 562 M€ | +1.54% | ||
| 2.13% | 2 M€ | +10.58% | ||
| 1.97% | 0 M€ | -.--% | ||
| 1.50% | 24 M€ | +0.98% | - | |
| 1.50% | 26 M€ | +1.12% | - | |
| 1.50% | 224 M€ | +4.20% | - | |
| 1.48% | 1 M€ | +2.21% | - | |
| 1.48% | 8 M€ | 0.00% | ||
| 1.40% | 9 M€ | -4.31% | - | |
| 1.24% | 85 M€ | +13.83% | - | |
| 1.24% | 13,519 M€ | +7.14% | ||
| 1.07% | 375 M€ | +9.35% | ||
| 1.04% | 800 M€ | +6.56% | ||
| 1.00% | 26 M€ | +21.55% | - | |
| 0.98% | 0 M€ | 0.00% | - | |
| 0.90% | 6 M€ | +17.98% | - |
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.92
USD
Average target price
31.94
USD
Spread / Average Target
+10.44%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +0.45% | 164B | |
| +32.36% | 694B | |
| +29.62% | 593B | |
| -1.60% | 371B | |
| +20.07% | 331B | |
| +6.04% | 290B | |
| +14.40% | 239B | |
| +10.36% | 209B | |
| -3.31% | 209B | |
| +9.27% | 169B |
- Stock Market
- Equities
- PFE Stock
- Funds and ETFs Pfizer, Inc.
